Biotechs in general have not been doing so well due to the...

  1. 128 Posts.
    Biotechs in general have not been doing so well due to the credit crunch, though many of these businesses are not affected by credit.

    One in particular, Cordlife, has plummeted in the last week or tw. A brief analysis can be found in:

    http://ozstock.blogspot.com/2008/04/brief-cbb-cordlife-limited.html
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.